02 Jul July 2, 2020 – TV Star James Murray, Authenticated Purchases Ray Salem and Strokes Dr. Patrick Lyden
“The audio file was removed when we switched hosts. Sorry. The cost was prohibitive. If you need the file, contact us and we will send it.”
Make it bullet proof, have thought out your product,
know who your customer is, don’t give up.
James Stephen Murray is a writer, executive producer, and actor, best known as “Murr” on truTV’s Impractical Jokers, the #1 show on Comedy Central in the United Kingdom and India. He is also one of the stars of the TV show The Misery Index on TBS along with his comedy troupe, The Tenderloins. James has worked as the Senior Vice President of Development for NorthSouth Productions for over a decade. James is also the best-selling author of several sci-fi thrillers, including his latest one, Obliteration: An Awakened Novel.
Amazon writes off $20 billion a year for counterfeit merchandise.
Ray Salem is the Founder and CEO of Authentiacte Pro, a company that provides a simple and unique authentication process to provide the peace of mind for buyers, and to enable sellers to differentiate themselves in the e-commerce brick and mortar retail marketplace. After launching it’s Beta service in 2019, Authenticate Pro has proven to increase sales for retailers by using its service. Ray is passionate about helping others and making a difference in someone’s life or their business. As a former social worker, he loves to make the world a better place. Ray has also committed to donate personal profits to Life Impact International, and he is committed to taking a percentage of profits of the company to help fight human trafficking as well as child labor.
Dr. Patrick Lyden – Professor of Neurolgy at Cedars-Sinai Medical Center
The number of strokes is the same. People are having stroke or
heart attack and they are not coming in. We are losing the
chance to reverse the effect of that stroke.
Patrick D. Lyden, MD, a world-renowned stroke expert, is a Professor of Neurology and the Carmen and Louis Warschaw Chair in Neurology, Cedars-Sinai Medical Center. Professor Lyden has been one of the key researchers in the major clinical trial for t-PA, which remains the only proven and approved drug treatment for stroke. In addition to his work on tPA, Lyden led the world’s largest study of therapeutic cooling to reduce brain injury after stroke. Professor Lyden also has a laboratory effort called Lyden Laboratory, funded by the National Institutes of Health (NIH), VA and American Heart Association, focused on translational preclinical stroke modeling, pharmacology, and vascular biology. In 2019, he was awarded the prestigious William M. Feinberg Award for Excellence in Clinical Stroke by the American Heart Association.